Goal #1: Advance clinical and translational science

Living kidney donation, in which a living person donates one kidney to another in need, offers the best outcomes for many kidney patients. However, the pool of living donors is limited, partly due to the exclusion of potential donors with a high body mass index (BMI).&nbsp;Next month, researchers from the University of Texas Medical Branch (UTMB) and Houston Methodist will launch a new study aimed at developing recommendations and tools to support ethical and equitable decisions about living donation by potential donors with high BMIs…&nbsp;Read the full article <a href="https://www.utmb.edu/its/welcome/news/2024/08/29/ethics-of-screening-for-obesity-in-organ-donation" target="_blank" rel="noopener noreferrer">here</a>.

University of Texas Medical Branch Institute for Translational Sciences

thumbnail_stock-photo-of-a-doctor-talking-to-a-patient.webp

stock-photo-of-a-doctor-talking-to-a-patient.webp

University of Texas M. D. Anderson Cancer Center

Ethics of Screening for Obesity in Organ Donation

- Any -

Goal #6: Enhance training programs 

Mentorship is critical for career and skill development in clinical and translational research, but locating practical resources on how to initiate, build, maintain, and assess these relationships is often challenging. To fill this gap, Harvard Catalyst has developed a new guide with popular resources adapted from their course and program content to help both mentees and mentors at all career stages maximize their relationships and grow their networks. Read the full article <a href="https://catalyst.harvard.edu/mentorship-in-clinical-and-translational-research/" target="_blank" rel="noopener noreferrer">here</a>.

Harvard Clinical and Translational Science Center

Harvard Catalyst. Mentorship in Clinical and Translational Research. A guide to empower mentees and mentors in maximizing their mentoring relationships and growing their networks.

large_harvard mentorship.PNG

medium_harvard mentorship.PNG

small_harvard mentorship.PNG

thumbnail_harvard mentorship.PNG

harvard mentorship.PNG

Harvard University

Harvard Clinical and Translational Science Center's New Guide on Mentorship in Clinical and Translational Research

X-logo-teal_80x66.png

ri_linkedin_fill_408497d4b5_96748f4451.png

Philip A. Kern, M.D., professor of internal medicine/endocrinology and co-director of the <a href="https://www.ccts.uky.edu/" target="_blank" rel="noopener noreferrer">University of Kentucky Center for Clinical and Translational Science (CCTS)</a>, is co-principal investigator of an innovative new research project examining gene expression and regulatory activity in multiple metabolic cells—specifically, alterations to messenger RNA (mRNA)—that lead to the development of type 2 diabetes and obesity, with the goal of identifying potential targets for innovative treatments for the chronic conditions. Rohit N. Kulkarni, M.D., Ph.D., the Diabetes Research and Wellness Foundation Endowed Chair and Co-Head of the Section on Islet &amp; Regenerative Biology at the Joslin Diabetes Center at Beth Israel Lahey Health, is the lead principal investigator on the five-year, $9,920,607 award from the <a href="https://www.niddk.nih.gov/" target="_blank" rel="noopener noreferrer">National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</a>, part of the National Institutes of Health (NIH). Additional co-principal investigators include Dr. Kern, as well as Chuan He, Ph.D., John T. Wilson Distinguished Service Professor, the University of Chicago; Mengjie Chen, Ph.D., Associate Professor of Medicine, Human Genetics and Statistics at the University of Chicago; and Ali Naji, M.D., Ph.D., Professor of Surgery, Associate Director of the Institute for Diabetes, Obesity and Metabolism at the University of Pennsylvania Perelman School of Medicine…&nbsp;Read the full article <a href="https://www.ccts.uky.edu/news/kern-co-leads-10-million-nihniddk-grant-pioneering-diabetes-and-obesity-research" target="_blank" rel="noopener noreferrer">here</a>.

Kentucky Center for Clinical and Translational Science

medium_philip kern.jpg

small_philip kern.jpg

thumbnail_philip kern.jpg

philip kern.jpg

University of Kentucky

Philip A. Kern, M.D., Co-Leads $10 Million NIH/NIDDK Grant for Pioneering Diabetes and Obesity Research

CTSA CCOS

Home

About

CTSA Groups and Meetings

Resources

News

Help

CTSA News

Date

Share this News Post

Ethics of Screening for Obesity in Organ Donation